CA2244608A1 - Nutritional product with high fat, low carbohydrate and amino acid imbalance - Google Patents
Nutritional product with high fat, low carbohydrate and amino acid imbalanceInfo
- Publication number
- CA2244608A1 CA2244608A1 CA002244608A CA2244608A CA2244608A1 CA 2244608 A1 CA2244608 A1 CA 2244608A1 CA 002244608 A CA002244608 A CA 002244608A CA 2244608 A CA2244608 A CA 2244608A CA 2244608 A1 CA2244608 A1 CA 2244608A1
- Authority
- CA
- Canada
- Prior art keywords
- nutritional product
- amino acid
- high fat
- low carbohydrate
- acid imbalance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 229930195722 L-methionine Natural products 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000005907 cancer growth Effects 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
A nutritional product is provided for cancer patients comprising, as per caloric requirement, a low concentration of carbohydrate, a high concentration of fat and an imbalance of amino acids wherein L-phenylalanine, L-tyrosine and L-methionine are present in the below normal concentrations and L-leucine is present in substantial excess of normal concentrations to suppress cancer growth and as an adjunct to conventional cancer therapies.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/997,837 US5817695A (en) | 1997-12-24 | 1997-12-24 | Nutritional product with high fat, low carbohydrate and amino acid imbalance |
US08/997,837 | 1997-12-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2244608A1 true CA2244608A1 (en) | 1999-06-24 |
CA2244608C CA2244608C (en) | 2002-12-17 |
Family
ID=25544458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002244608A Expired - Fee Related CA2244608C (en) | 1997-12-24 | 1998-07-31 | Nutritional product with high fat, low carbohydrate and amino acid imbalance |
Country Status (5)
Country | Link |
---|---|
US (1) | US5817695A (en) |
EP (1) | EP0925726B1 (en) |
CA (1) | CA2244608C (en) |
DE (1) | DE69821329T2 (en) |
ES (1) | ES2215278T3 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6322826B2 (en) * | 1998-06-16 | 2001-11-27 | Mathias Christian Zohoungbogbo | Dietetic food composition and dietetic method using such composition |
DK0951842T3 (en) * | 1999-01-20 | 2003-01-06 | Nutricia Nv | Nutritional product for an infant |
US20020132781A1 (en) * | 2000-10-06 | 2002-09-19 | George Kindness | Combination and method of treatment of cancer utilizing a COX-2 inhibitor and A 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA) reductase inhibitor |
US6506412B2 (en) * | 2000-11-29 | 2003-01-14 | Sciencebased Health | Treatment of dry eye syndrome |
US20030129262A1 (en) * | 2001-08-30 | 2003-07-10 | Epner Daniel E. | Methionine restriction for cancer therapy |
US20030105104A1 (en) * | 2001-11-27 | 2003-06-05 | Burzynski Stanislaw R. | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
US6939860B2 (en) * | 2002-01-08 | 2005-09-06 | Matthias Rath | Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
YU75003A (en) * | 2002-01-11 | 2006-08-17 | Matthias Rath | A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
ATE383076T1 (en) * | 2002-02-04 | 2008-01-15 | Bristol Myers Squibb Co | BREAST MILK SUPPLEMENT |
CA2493764C (en) * | 2002-08-01 | 2011-05-24 | Aesgen, Inc. | Improved treatment of cancer with glutamine |
US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
US20040091518A1 (en) * | 2002-11-07 | 2004-05-13 | Welser Jennifer L. | Lysine mixture and apparatus and method for administering lysine |
US20040120983A1 (en) * | 2002-12-23 | 2004-06-24 | Philip Connolly | Nutritional supplement |
US20050118235A1 (en) * | 2003-12-02 | 2005-06-02 | Shiguang Yu | Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
WO2007002837A2 (en) * | 2005-06-29 | 2007-01-04 | Hill's Pet Nutrition, Inc. | Methods and compositions for the prevention and treatement of inflammatory disease |
EP1957061B1 (en) * | 2005-11-30 | 2011-05-11 | Nestec S.A. | Combination comprising at least one amino acid and a pkr inhibitor for use in the treatment of muscle loss |
JP2009519328A (en) * | 2005-12-16 | 2009-05-14 | エヌ.ブイ.・ヌートリシア | Use of soluble dietary fiber for muscle atrophy |
DE102007013903A1 (en) * | 2007-03-20 | 2008-09-25 | Coy, Johannes F., Dr. | drink |
JPWO2008123298A1 (en) * | 2007-03-26 | 2010-07-15 | 裕史 松井 | Infusion formulation for cancer patients |
WO2011045810A1 (en) | 2009-08-13 | 2011-04-21 | Zota Health Care Limited | Pharmaceutical compositions containing taurine and race-methionine for the treatment of alcoholism |
WO2013124860A1 (en) | 2012-02-23 | 2013-08-29 | Zota Health Care Ltd | Potent revital formulation |
WO2015177805A1 (en) | 2014-05-19 | 2015-11-26 | Zota Health Care Ltd | Combination of taurine and racemethionine for treatment of liver diseases |
US11344497B1 (en) | 2017-12-08 | 2022-05-31 | Quicksilver Scientific, Inc. | Mitochondrial performance enhancement nanoemulsion |
US10722465B1 (en) | 2017-12-08 | 2020-07-28 | Quicksilber Scientific, Inc. | Transparent colloidal vitamin supplement |
US11291702B1 (en) | 2019-04-15 | 2022-04-05 | Quicksilver Scientific, Inc. | Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5081105A (en) * | 1988-01-15 | 1992-01-14 | New England Deaconess Hospital Corporation | Method of treating cancer using structured lipids |
JPH01301619A (en) * | 1988-05-30 | 1989-12-05 | Otsuka Pharmaceut Factory Inc | Amino acid pharmaceutical for cancer |
US5132113A (en) * | 1990-10-26 | 1992-07-21 | Maurizio Luca | Nutritional composition containing essential amino acids |
JP3429327B2 (en) * | 1992-07-20 | 2003-07-22 | 味の素ファルマ株式会社 | Amino acid infusion for cancer |
US5547927A (en) * | 1993-05-28 | 1996-08-20 | Abbott Laboratories | Enteral nutritional product for patients undergoing radiation therapy and/or chemotherapy |
US5661123A (en) * | 1995-01-17 | 1997-08-26 | Nestec, Ltd. | Enteral composition for malabsorbing patients |
-
1997
- 1997-12-24 US US08/997,837 patent/US5817695A/en not_active Expired - Lifetime
-
1998
- 1998-07-31 CA CA002244608A patent/CA2244608C/en not_active Expired - Fee Related
- 1998-10-02 ES ES98308062T patent/ES2215278T3/en not_active Expired - Lifetime
- 1998-10-02 DE DE1998621329 patent/DE69821329T2/en not_active Expired - Lifetime
- 1998-10-02 EP EP98308062A patent/EP0925726B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5817695A (en) | 1998-10-06 |
ES2215278T3 (en) | 2004-10-01 |
EP0925726B1 (en) | 2004-01-28 |
CA2244608C (en) | 2002-12-17 |
DE69821329D1 (en) | 2004-03-04 |
DE69821329T2 (en) | 2004-11-18 |
EP0925726A1 (en) | 1999-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2244608A1 (en) | Nutritional product with high fat, low carbohydrate and amino acid imbalance | |
EP0764405B1 (en) | Nutritional composition | |
CA2128078A1 (en) | Nutritional product for trauma and surgery patients | |
EP0044032B2 (en) | Process for producing a low-molecular weight peptide composition and nutrient agent containing the same | |
EP0144051A3 (en) | Dietetic supplement and prepackaged food in which it is contained. process of preparation and method of administration | |
NZ310705A (en) | High moisture nutrient formulation containing at least 50% water, at least 8% digestible carbohydrates and at least 7% of an amino acid source | |
US5756481A (en) | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction in animals and man | |
AU5763094A (en) | Composition and method for treating patients with hepatic disease | |
CA2331854A1 (en) | Nutritional product for a person having renal failure | |
PT83983B (en) | METHOD FOR PREPARING CONCENTRATES OF BEVERAGES CONTAINING A CALCIUM NUTRITIVE SUPPLEMENT | |
US3849554A (en) | Reduction of blood serum cholesterol | |
CA2385860A1 (en) | Composition comprising casein protein and whey protein | |
CA2371696A1 (en) | Composition for an infant formula having a low threonine content | |
CA2318566A1 (en) | Gelled foods and process for producing the same | |
AU4003999A (en) | Healthbar formulations | |
CA2054358A1 (en) | High acid nutritional formulations | |
CA2177195A1 (en) | Method and composition for treating renal failure | |
CA2221455A1 (en) | Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids | |
IL128153A0 (en) | Nutritional formula for phenylketonuria patients | |
RU2001127667A (en) | NUTRITIONAL COMPOSITION INTENDED FOR THE DEVELOPMENT OF GASTROINTESTINAL TRACT IN PREMATURAL MAMMALS | |
CA2320991A1 (en) | Calorically dense nutritional composition | |
AU5767390A (en) | Improved nutritional formulation for the treatment of renal disease | |
EP0680945A3 (en) | Amino acid, carnitine and magnesium supplementation | |
WO1999048384A3 (en) | Food containing biotin and other b vitamins | |
CA2251916A1 (en) | Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20160801 |
|
MKLA | Lapsed |
Effective date: 20160801 |